Elizabeth Cermak Insider Profile
4 Followers
Elizabeth Cermak, Director at Moleculin Biotech, holds ― shares in Moleculin Biotech (Ticker: MBRX), holds 0.00 shares in Steadymed (Ticker: STDY), holds 5.77K shares in Clarus Therapeutics Holdings (Ticker: CRXTQ).
Elizabeth Cermak's Trading History
| CRXTQClarus Therapeutics Holdings | Jun 09, 2022 | ― | Uninformative Buy | ― | $57.66 | |
| ARLZQAralez Pharmaceuticals | Mar 15, 2013 | ― | Uninformative Buy | ― | $40.00 | |
| STDYSteadymed | ― | ― | ― | $0.00 | ||
| MBRXMoleculin Biotech | ― | Director | ― | ― |
You May Also Like
Elizabeth Cermak insider profile FAQ
What stocks does Elizabeth Cermak hold?
Elizabeth Cermak holds: MBRX, STDY, CRXTQ, ARLZQ stocks.
What was Elizabeth Cermak's most profitable transaction?
Elizabeth Cermak’s most profitable transaction was an Informative Buy of ARLZQ stock on March 16, 2011. The return on the trade was 5.70%.
What is Elizabeth Cermak's role in Moleculin Biotech?
Elizabeth Cermak's role in Moleculin Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
